Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Is this the most promising DLL3-targeting therapy yet? Zai Lab advances ADC into Phase 3 Zai Lab’s DLL3-targeting ADC for small cell lung cancer shows high brain metastasis activity; global Phase 3 trial now underway. Explore the data and future impact. byPallavi MadhirajuOctober 25, 2025